All News

2057 articles, sorted by publication time.

Biotechnology Regulation · us

From Manufacturing to Release: FDA Finalizes Potency Assurance Guidance for Cell and Gene Therapies

Whether a batch of a therapy delivers its expected biological activity depends on how materials, manufacturing processes, and testing work together to ensure quality. FDA has updated guidance used for 15 years, extending its quality management perspective across the entire product lifecycle while retaining flexibility based on the stage of development.

Cancer and Immunotherapy · global

From Tumor Sequencing to Personalized Vaccines: India’s PopVax Launches mRNA Cancer Vaccine Manufacturing Service

Making a vaccine for each patient involves more than identifying cancer cell markers; it also requires timely, consistent manufacturing. PopVax proposes delivery within eight to ten weeks, but its cancer vaccines have not yet been used in humans, and their efficacy and safety remain to be established in clinical trials.